<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="systematic-review" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2024.1510729</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurology</subject>
<subj-group>
<subject>Systematic Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The application of artificial intelligence in diagnosis of Alzheimer&#x2019;s disease: a bibliometric analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>An</surname> <given-names>Xiaoqiong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn0002"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1842917/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>He</surname> <given-names>Jun</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn0002"><sup>&#x2020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Bi</surname> <given-names>Bin</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wu</surname> <given-names>Gang</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Xu</surname> <given-names>Jianwei</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yu</surname> <given-names>Wenfeng</given-names></name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Ren</surname> <given-names>Zhenkui</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff8"><sup>8</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1586931/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Laboratory Medicine, The Second People's Hospital of Guizhou Province</institution>, <addr-line>Guiyang</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Guizhou Provincial Center for Clinical Laboratory</institution>, <addr-line>Guiyang</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Psychosomatic Department, The Second People's Hospital of Guizhou Province</institution>, <addr-line>Guiyang</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Center for Tissue Engineering and Stem Cell Research, Guizhou Medical University</institution>, <addr-line>Guiyang</addr-line>, <country>China</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Pharmacology, School of Basic Medicine, Guizhou Medical University</institution>, <addr-line>Guiyang</addr-line>, <country>China</country></aff>
<aff id="aff6"><sup>6</sup><institution>Key Laboratory of Molecular Biology, Guizhou Medical University</institution>, <addr-line>Guiyang</addr-line>, <country>China</country></aff>
<aff id="aff7"><sup>7</sup><institution>Key Laboratory of Human Brain Bank for Functions and Diseases of Department of Education of Guizhou Province, Guizhou Medical University</institution>, <addr-line>Guiyang</addr-line>, <country>China</country></aff>
<aff id="aff8"><sup>8</sup><institution>Laboratory Department of People&#x2019;s Hospital of Southwest Guizhou Autonomous Prefecture</institution>, <addr-line>Xingyi</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0003">
<p>Edited by: Alessia Sarica, University of Magna Graecia, Italy</p>
</fn>
<fn fn-type="edited-by" id="fn0004">
<p>Reviewed by: Stavros I. Dimitriadis, University of Barcelona, Spain</p>
<p>Federica Aracri, University of Magna Graecia, Italy</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Jianwei Xu, <email>xujianwei@gmc.edu.cn</email>; Wenfeng Yu, <email>wenfengyu2013@126.com</email>; Zhenkui Ren, <email>2639092792@qq.com</email></corresp>
<fn fn-type="equal" id="fn0002">
<p><sup>&#x2020;</sup>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1510729</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>10</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>11</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 An, He, Bi, Wu, Xu, Yu and Ren.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>An, He, Bi, Wu, Xu, Yu and Ren</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Alzheimer&#x2019;s disease (AD) is a neurodegenerative disorder that severely impacts cognitive function, posing significant physical and psychological burdens on patients and substantial economic challenges to families and society, particularly in aging populations where its prevalence is rising. Current diagnostic and therapeutic strategies, including pharmacological treatments and non-pharmacological interventions, exhibit considerable limitations in early diagnosis, etiological treatment, and disease management. This study aims to investigate the application of artificial intelligence (AI) in the early diagnosis and progression monitoring of AD through a bibliometric analysis of relevant literature. A systematic search in the Web of Science Core Collection identified 530 publications related to AI and AD, consisting of 361 original research articles and 169 review articles, with a notable increase in annual publication rates, particularly between 2019 and 2024. The United States and China emerged as leading contributors, emphasizing the importance of international collaboration. Institutional analysis revealed that Harvard University and Indiana University System are at the forefront, highlighting the role of academic institutions in fostering interdisciplinary research. Furthermore, the Journal of Alzheimer&#x2019;s Disease was identified as the most influential publication outlet. Key highly cited papers provided essential theoretical foundations for ongoing research. This study underscores the growing relevance of AI in AD research and suggests promising avenues for future investigations, particularly in enhancing diagnostic accuracy and therapeutic strategies through advanced data analytics and machine learning techniques.</p>
</abstract>
<kwd-group>
<kwd>Alzheimer&#x2019;s disease</kwd>
<kwd>artificial intelligence</kwd>
<kwd>Bibliometrix</kwd>
<kwd>CiteSpace</kwd>
<kwd>VOSviewer</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="5"/>
<equation-count count="0"/>
<ref-count count="42"/>
<page-count count="18"/>
<word-count count="7901"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Artificial Intelligence in Neurology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<label>1</label>
<title>Introduction</title>
<p>Alzheimer&#x2019;s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and behavioral changes, significantly impacting patients and their families, as well as imposing a substantial economic burden on healthcare systems worldwide (<xref ref-type="bibr" rid="ref1">1</xref>, <xref ref-type="bibr" rid="ref2">2</xref>). The increasing prevalence of AD, projected to affect over 150 million individuals by 2050, necessitates urgent advancements in diagnostic and therapeutic strategies (<xref ref-type="bibr" rid="ref3">3</xref>, <xref ref-type="bibr" rid="ref4">4</xref>). Current approaches primarily rely on clinical assessments and neuroimaging techniques, which, while valuable, often fall short in early detection and personalized treatment, leading to delayed interventions and suboptimal patient outcomes.</p>
<p>Despite substantial investments in drug development aimed at AD, there has been a conspicuous lack of breakthrough advancements, with existing treatments often yielding suboptimal outcomes (<xref ref-type="bibr" rid="ref5">5</xref>). This stagnation underscores the urgent need for innovative approaches to enhance our understanding of AD&#x2019;s complex pathophysiology and to identify potential therapeutic targets (<xref ref-type="bibr" rid="ref6">6</xref>). Previous studies have elucidated various mechanisms underlying AD, including amyloid-beta accumulation, tau protein hyperphosphorylation, and neuroinflammation, yet these findings have not translated into effective clinical solutions (<xref ref-type="bibr" rid="ref7">7</xref>, <xref ref-type="bibr" rid="ref8">8</xref>, <xref ref-type="bibr" rid="ref9">9</xref>).</p>
<p>The integration of artificial intelligence (AI) into the diagnosis and treatment of Alzheimer&#x2019;s disease has emerged as a pivotal advancement in the field of neurology and geriatric medicine (<xref ref-type="bibr" rid="ref10">10</xref>, <xref ref-type="bibr" rid="ref11">11</xref>). By analyzing vast datasets derived from neuroimaging, genetic information, and clinical assessments, AI systems can identify biomarkers that may be overlooked by traditional diagnostic methods (<xref ref-type="bibr" rid="ref12">12</xref>). Furthermore, AI-driven tools facilitate the development of predictive models that can forecast the onset of Alzheimer&#x2019;s disease in at-risk populations, thereby enabling early intervention and improved patient outcomes (<xref ref-type="bibr" rid="ref13">13</xref>). The application of AI in this context not only streamlines clinical workflows but also fosters a more nuanced understanding of the complex pathophysiology of Alzheimer&#x2019;s disease, ultimately contributing to the advancement of precision medicine in neurodegenerative disorders.</p>
</sec>
<sec sec-type="materials|methods" id="sec2">
<label>2</label>
<title>Materials and methods</title>
<sec id="sec3">
<label>2.1</label>
<title>Data source and search strategy</title>
<p>Due to its comprehensive coverage of over 12,000 academic journals and its frequent use by researchers, Web of Science was selected as the primary database for this study. Compared with other databases such as Scopus, Medline, and PubMed, Web of Science provides the most comprehensive and reliable bibliometric analysis (<xref ref-type="bibr" rid="ref14">14</xref>). The Web of Science Core Collections Database (WOSCC) was searched on September 8, 2024, for literature on artificial intelligence and Alzheimer&#x2019;s disease published between January 1, 2010, and September 8, 2024. To reduce the bias caused by frequent database updates, we completed the search in 1 day. There was a search formula set as follows: [TS&#x202F;=&#x202F;(Alzheimer&#x2019;s disease) or (Alzheimer) or (Alzheimer&#x2019;s disease (AD)) or (AD) or (Alzheimer&#x2019;s disease) or (Alzheimer Diseases) or (Alzheimer&#x2019;s Diseases)] and [TS&#x202F;=&#x202F;(artificial intelligence) or (AI) or (artificial-intelligence)] and [LA&#x202F;=&#x202F;(English)]. In this study, only articles and reviews were considered (editorials, proceedings papers, abstracts, and book chapters were excluded), with a time frame from January 1, 2010, to September 8, 2024. <xref ref-type="fig" rid="fig1">Figure 1</xref> illustrates how paper screening is conducted. Finally, in order to ensure data quality, we perform data cleansing, which includes the removal of duplicate records, uniform formatting of author names and dates, and handling of missing values. For records with critical information missing, we adopted a strategy of either filling in or excluding the records.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Flowchart of the bibliometric search and analysis process.</p>
</caption>
<graphic xlink:href="fneur-15-1510729-g001.tif"/>
</fig>
</sec>
<sec id="sec4">
<label>2.2</label>
<title>Statistical analysis</title>
<p>Bibliometric analysis often involves the application of mathematical and statistical methods to scrutinize research outcomes, with the goal of extracting meaningful information and identifying dominant patterns within extensive scholarly works (<xref ref-type="bibr" rid="ref15">15</xref>, <xref ref-type="bibr" rid="ref16">16</xref>). This analytical approach offers insights into various bibliometric dimensions, including countries, institutions, journals, authors, keywords, and citations, presenting a holistic dataset encompassing these elements (<xref ref-type="bibr" rid="ref17">17</xref>). Moreover, through visualization, it becomes possible to evaluate the ongoing research advancements in specific domains and to foresee emerging trends and focal points (<xref ref-type="bibr" rid="ref18">18</xref>). In the field of bibliometrics, VOSviewer, CiteSpace, and Bibliometrix are three software tools designed for the analysis of scientific literature networks (<xref ref-type="bibr" rid="ref19">19</xref>).</p>
<p>VOSviewer is a software tool for constructing and visualizing scientific literature networks (<xref ref-type="bibr" rid="ref20">20</xref>). It processes citation, co-citation, co-word, and co-authorship data, generating intuitive scientific maps that help researchers identify research trends and knowledge structures (<xref ref-type="bibr" rid="ref21">21</xref>). The software offers three types of visualizations: network view, overlay view, and density view (<xref ref-type="bibr" rid="ref22">22</xref>). In our study, we conducted an in-depth bibliometric analysis using VOSviewer software. Initially, we set the analysis parameters based on our research objectives, including the time frame, node types, relationship strengths, threshold, clustering algorithm, clustering parameters, and visualization parameters to ensure the precision and relevance of the results. Subsequently, the software automatically constructed collaboration and co-citation networks based on these parameters, visually displaying the interrelationships and knowledge flow among literature. Finally, we generated various charts, including collaboration and co-citation network diagrams, which revealed the structure and dynamics within the research field. Through this process, we were able to clearly present and analyze key collaborations and knowledge development paths within the research area.</p>
<p>CiteSpace, based on the Java platform, it offers an intuitive approach to analyzing and visualizing large volumes of literature data, especially suitable for handling information from various academic database and helps researchers discover research hotspots and future trends in scientific literature (<xref ref-type="bibr" rid="ref23">23</xref>, <xref ref-type="bibr" rid="ref24">24</xref>). In this study, we employed CiteSpace version 6.3.R1 to perform a comprehensive bibliometric analysis, which included the generation of clustering maps to visualize reference and keyword relationships and timeline visualizations to track the evolution of references over time. The software also enabled us to identify citation bursts within references, indicating significant research waves. Additionally, we conducted a dual-map analysis of journals to explore shifts in research directions and trends, revealing key themes and influential journals in the field. To achieve this, we set parameters such as time span, node types, relationship strengths, and co-occurrence thresholds, and leveraged CiteSpace&#x2019;s clustering algorithms, including LSI, LLR, and MI, to identify research topics and trends. The software facilitated the extraction of terms from the titles, keywords, and abstracts of the literature, allowing us to construct collaboration and co-citation networks. These networks were then used to generate intuitive charts that illuminated the structure and dynamics of the research field, providing a clear overview of the key topics and influential publications.</p>
<p>Bibliometrix is an R package that covers the entire workflow of scientific mapping, from data collection to analysis and visualization (<xref ref-type="bibr" rid="ref25">25</xref>). These tools enable researchers to identify research hotspots, trends, and patterns, providing valuable insights for academic studies. In addition, a bibliometric platform<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref> is used to visualize international collaboration.</p>
</sec>
</sec>
<sec sec-type="results" id="sec5">
<label>3</label>
<title>Results</title>
<sec id="sec6">
<label>3.1</label>
<title>Data general</title>
<p>Following our search criteria, we identified a total of 530 research works related to artificial intelligence and Alzheimer&#x2019;s disease since 2010, comprising 361 original articles and 169 review papers. There has been a consistent annual increase in the number of publications, with a particularly dramatic surge observed between 2019 and 2024. Even with only partial data for 2024, the count has already exceeded 133 articles, indicating a persistent upward trajectory. However, there was a negligible amount of related research prior to 2015 (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Annual worldwide publication output.</p>
</caption>
<graphic xlink:href="fneur-15-1510729-g002.tif"/>
</fig>
</sec>
<sec id="sec7">
<label>3.2</label>
<title>An analysis of the most productive countries/regions</title>
<p>A total of 76 countries/regions participated in research on artificial intelligence and Alzheimer&#x2019;s disease between 2010 and 2024. The top 10 countries/regions with significant contributions and notable associations are presented in <xref ref-type="table" rid="tab1">Table 1</xref>, it can reflect the countries/regions that have made the most significant contributions in this area. <xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="table" rid="tab1">Table 1</xref> show the top 10 countries and institutions according to publication number, and the top 5 countries are the United States, China, India, England and Italy. <xref ref-type="table" rid="tab1">Table 1</xref> indicates that the United States has a leading role with 152 publications, highlighting its significant contribution to the field. China follows with a notable 100 publications, indicating a strong research presence. India&#x2019;s 60 publications reflect an emerging research force, while England&#x2019;s 50 and Italy&#x2019;s 44 demonstrate their active engagement in the area. In the analysis of citations per publication, Germany secured the top position with an average of 20.88 citations per publication, followed closely by Italy with 18.18 citations per publication. The United States and England made significant advancements, claiming the third and fourth spots with 17.86 and 17.04 citations per publication, respectively. Additionally, we examined the collaborative ties between nations, with lines connecting two countries signifying the presence of cooperative relationships, the analysis of the global country collaboration network illustrates the interconnectedness and collaborative efforts among various nations in the field. As illustrated in <xref ref-type="fig" rid="fig3">Figures 3B</xref>,<xref ref-type="fig" rid="fig3">C</xref>, the analysis revealed a pattern of intensified collaboration among a select group of countries. Specifically, the United States, the United Kingdom, Canada, India, China, and France exhibited a higher degree of cooperative engagement with one another. The strength of these connections implies a significant impact on the collective advancement of research and innovation in their respective fields of study.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Top 10 countries/regions publishing research related to AI in Alzheimer&#x2019;s disease.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Rank</th>
<th align="left" valign="top">Country/region</th>
<th align="center" valign="top">Publications</th>
<th align="center" valign="top">Citations</th>
<th align="center" valign="top">citations per publication</th>
<th align="center" valign="top">Total link strength</th>
<th align="center" valign="top">Links</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">1</td>
<td align="left" valign="top">United States</td>
<td align="center" valign="top">152</td>
<td align="center" valign="top">2,714</td>
<td align="char" valign="top" char=".">17.86</td>
<td align="center" valign="top">121</td>
<td align="center" valign="top">32</td>
</tr>
<tr>
<td align="left" valign="top">2</td>
<td align="left" valign="top">Peoples R China</td>
<td align="center" valign="top">100</td>
<td align="center" valign="top">1,253</td>
<td align="char" valign="top" char=".">12.53</td>
<td align="center" valign="top">64</td>
<td align="center" valign="top">23</td>
</tr>
<tr>
<td align="left" valign="top">3</td>
<td align="left" valign="top">India</td>
<td align="center" valign="top">60</td>
<td align="center" valign="top">628</td>
<td align="char" valign="top" char=".">10.47</td>
<td align="center" valign="top">54</td>
<td align="center" valign="top">21</td>
</tr>
<tr>
<td align="left" valign="top">4</td>
<td align="left" valign="top">England</td>
<td align="center" valign="top">50</td>
<td align="center" valign="top">852</td>
<td align="char" valign="top" char=".">17.04</td>
<td align="center" valign="top">93</td>
<td align="center" valign="top">27</td>
</tr>
<tr>
<td align="left" valign="top">5</td>
<td align="left" valign="top">Italy</td>
<td align="center" valign="top">44</td>
<td align="center" valign="top">800</td>
<td align="char" valign="top" char=".">18.18</td>
<td align="center" valign="top">52</td>
<td align="center" valign="top">22</td>
</tr>
<tr>
<td align="left" valign="top">6</td>
<td align="left" valign="top">South Korea</td>
<td align="center" valign="top">41</td>
<td align="center" valign="top">422</td>
<td align="char" valign="top" char=".">10.29</td>
<td align="center" valign="top">30</td>
<td align="center" valign="top">14</td>
</tr>
<tr>
<td align="left" valign="top">7</td>
<td align="left" valign="top">Spain</td>
<td align="center" valign="top">33</td>
<td align="center" valign="top">510</td>
<td align="char" valign="top" char=".">15.45</td>
<td align="center" valign="top">55</td>
<td align="center" valign="top">26</td>
</tr>
<tr>
<td align="left" valign="top">8</td>
<td align="left" valign="top">Australia</td>
<td align="center" valign="top">28</td>
<td align="center" valign="top">392</td>
<td align="char" valign="top" char=".">14.00</td>
<td align="center" valign="top">38</td>
<td align="center" valign="top">20</td>
</tr>
<tr>
<td align="left" valign="top">9</td>
<td align="left" valign="top">Germany</td>
<td align="center" valign="top">26</td>
<td align="center" valign="top">543</td>
<td align="char" valign="top" char=".">20.88</td>
<td align="center" valign="top">51</td>
<td align="center" valign="top">20</td>
</tr>
<tr>
<td align="left" valign="top">10</td>
<td align="left" valign="top">Saudi Arabia</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">188</td>
<td align="char" valign="top" char=".">7.83</td>
<td align="center" valign="top">33</td>
<td align="center" valign="top">16</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Visualization of countries/regions in the research of AI-related AD during 2010&#x2013;2024. <bold>(A)</bold> The annual number of publications in major countries. <bold>(B)</bold> Publication distribution and collaboration between countries/regions. <bold>(C)</bold> Country/regional collaboration network. In the country/regional collaboration network, nodes represent individual countries or regions, and their sizes correspond to the publication volumes of each entity. The nodes of different colors represent the countries/regions with different clusters.</p>
</caption>
<graphic xlink:href="fneur-15-1510729-g003.tif"/>
</fig>
</sec>
<sec id="sec8">
<label>3.3</label>
<title>An analysis of the most productive institutions</title>
<p>It is estimated that over 1,228 institutions have contributed to the research on artificial intelligence and Alzheimer&#x2019;s disease. As shown in <xref ref-type="fig" rid="fig4">Figure 4A</xref>, seven of the top 10 most productive institutions were from the United States, as Harvard University ranks first with 47 publications, followed by Indiana University System in second position with 42 articles. In addition, the institutions with the third highest number of publications are University of London from the United Kingdom, with 33 articles published. It is clear that both the United States and the United Kingdom have significant influence in this field. In addition, we performed a bibliographic coupling analysis to explore the intellectual and research connections among institutions with a minimum threshold of 5 publications, as depicted in <xref ref-type="fig" rid="fig4">Figure 4B</xref>, from the 1,228 institutions initially considered, 39 met the criteria for inclusion in the analysis. This method, which discerns relationships through the co-citation of documents, offers a graphical depiction of the inter-institutional scholarly links. Harvard Medical School emerged with the most substantial total link strength, totaling 4,319, succeeded by University of Cambridge with 4,235, and the Alan Turing Institute with 3,880. Additionally, the overlay map visualization indicates that research on artificial intelligence and Alzheimer&#x2019;s disease has only rapidly developed in recent years, demonstrating the immense potential of artificial intelligence technology in the early diagnosis of Alzheimer&#x2019;s disease, monitoring disease progression, developing treatment strategies, and researching pathological mechanisms in the future.</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Analysis of institutions engaged in research on AI-related AD. <bold>(A)</bold> Top 10 most productive institutions based on publication performance. <bold>(B)</bold> Overlay visualization map of bibliographic coupling analysis of institutions. The size of each institution&#x2019;s name in the network diagram is proportional to the number of articles published by that institution. The curvature and thickness of the lines connecting institutions indicate the strength of their collaborative ties. Additionally, the circle&#x2019;s color gradients represent different time intervals within the study period.</p>
</caption>
<graphic xlink:href="fneur-15-1510729-g004.tif"/>
</fig>
</sec>
<sec id="sec9">
<label>3.4</label>
<title>An analysis of the journals and co-cited journals with the highest impact</title>
<p>A total of 282 distinct journals have published 530 articles in the field of artificial intelligence and Alzheimer&#x2019;s disease. Among these journals, five have over 10 papers published. <xref ref-type="table" rid="tab2">Table 2</xref> shows the top 10 journals/co-cited journals with the number of publications and citations/co-citations, and their corresponding Impact Factor (JCR 2023) and JCR quartile. As depicted in <xref ref-type="fig" rid="fig5">Figure 5A</xref> and <xref ref-type="table" rid="tab2">Table 2</xref>, the top 10 journals with the highest number of published articles are showcased. This ranking reflects the prolific contribution of these journals to the field, indicating their significant role in disseminating research findings and advancing scientific knowledge. Notably, the Journal of Alzheimer&#x2019;s Disease (IF&#x202F;=&#x202F;3.4, Q2) stands out prominently in the field, contributing 27 publications and a substantial total link strength of 346, emphasizing its significant role in advancing research on Alzheimer&#x2019;s disease. Closely trailing, the Diagnostics (IF&#x202F;=&#x202F;3, Q1) exhibits a notable presence as well, publishing 15 articles and achieving a total link strength of 154. Furthermore, the Frontiers in Aging Neuroscience (IF&#x202F;=&#x202F;4.1, Q2) has made a remarkable impact, published 15 articles, demonstrating an even higher total link strength of 434. These journals, frequently cited in the realm of Alzheimer&#x2019;s disease research, underscore their influential positions not only in the broader neuroscience community but also within the intersection of artificial intelligence and Alzheimer&#x2019;s disease studies.</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>The top 10 journals and the co-cited journals that published documents on AI related to AD.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Rank</th>
<th align="left" valign="top">Sources</th>
<th align="center" valign="top">Articles</th>
<th align="center" valign="top">Citations</th>
<th align="center" valign="top">Total link strength</th>
<th align="center" valign="top">IF (2023)</th>
<th align="center" valign="top">JCR (2023)</th>
<th align="left" valign="top">Co-cited journal</th>
<th align="center" valign="top">Co-citations</th>
<th align="center" valign="top">Total link strength</th>
<th align="center" valign="top">IF (2023)</th>
<th align="center" valign="top">JCR (2023)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">1</td>
<td align="left" valign="top">Journal of Alzheimers Disease</td>
<td align="center" valign="top">27</td>
<td align="center" valign="top">346</td>
<td align="center" valign="top">21</td>
<td align="center" valign="top">3.2</td>
<td align="center" valign="top">Q2</td>
<td align="left" valign="top">Alzheimers Dement</td>
<td align="center" valign="top">820</td>
<td align="center" valign="top">11,559</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">Q1</td>
</tr>
<tr>
<td align="left" valign="top">2</td>
<td align="left" valign="top">Diagnostics</td>
<td align="center" valign="top">15</td>
<td align="center" valign="top">154</td>
<td align="center" valign="top">17</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">Q1</td>
<td align="left" valign="top">Neuroimage</td>
<td align="center" valign="top">740</td>
<td align="center" valign="top">9,194</td>
<td align="center" valign="top">4.7</td>
<td align="center" valign="top">Q1</td>
</tr>
<tr>
<td align="left" valign="top">3</td>
<td align="left" valign="top">Frontiers in Aging Neuroscience</td>
<td align="center" valign="top">15</td>
<td align="center" valign="top">434</td>
<td align="center" valign="top">22</td>
<td align="center" valign="top">4.1</td>
<td align="center" valign="top">Q2</td>
<td align="left" valign="top">J Alzheimers Dis</td>
<td align="center" valign="top">696</td>
<td align="center" valign="top">11,031</td>
<td align="center" valign="top">3.4</td>
<td align="center" valign="top">Q2</td>
</tr>
<tr>
<td align="left" valign="top">4</td>
<td align="left" valign="top">IEEE Access</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">177</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">3.4</td>
<td align="center" valign="top">Q2</td>
<td align="left" valign="top">Sci Rep-UK</td>
<td align="center" valign="top">597</td>
<td align="center" valign="top">7,755</td>
<td align="center" valign="top">3.8</td>
<td align="center" valign="top">Q1</td>
</tr>
<tr>
<td align="left" valign="top">5</td>
<td align="left" valign="top">International Journal of Molecular Sciences</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">164</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">4.9</td>
<td align="center" valign="top">Q2</td>
<td align="left" valign="top">Plos One</td>
<td align="center" valign="top">542</td>
<td align="center" valign="top">7,975</td>
<td align="center" valign="top">2.9</td>
<td align="center" valign="top">Q1</td>
</tr>
<tr>
<td align="left" valign="top">6</td>
<td align="left" valign="top">Experimental and Molecular Medicine</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">23</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">9.5</td>
<td align="center" valign="top">Q2</td>
<td align="left" valign="top">Neurology</td>
<td align="center" valign="top">463</td>
<td align="center" valign="top">7,282</td>
<td align="center" valign="top">7.7</td>
<td align="center" valign="top">Q1</td>
</tr>
<tr>
<td align="left" valign="top">7</td>
<td align="left" valign="top">Frontiers in Neuroscience</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">338</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">3.2</td>
<td align="center" valign="top">Q1</td>
<td align="left" valign="top">Nature</td>
<td align="center" valign="top">380</td>
<td align="center" valign="top">4,564</td>
<td align="center" valign="top">50.5</td>
<td align="center" valign="top">Q1</td>
</tr>
<tr>
<td align="left" valign="top">8</td>
<td align="left" valign="top">Alzheimers and Dementia</td>
<td align="center" valign="top">7</td>
<td align="center" valign="top">116</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">Q1</td>
<td align="left" valign="top">Front Aging Neurosci</td>
<td align="center" valign="top">363</td>
<td align="center" valign="top">5,332</td>
<td align="center" valign="top">4.1</td>
<td align="center" valign="top">Q2</td>
</tr>
<tr>
<td align="left" valign="top">9</td>
<td align="left" valign="top">Alzheimers Research and Therapy</td>
<td align="center" valign="top">7</td>
<td align="center" valign="top">122</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">7.9</td>
<td align="center" valign="top">Q2</td>
<td align="left" valign="top">Arxiv</td>
<td align="center" valign="top">362</td>
<td align="center" valign="top">3,037</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">10</td>
<td align="left" valign="top">Ageing Research Reviews</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">49</td>
<td align="center" valign="top">7</td>
<td align="center" valign="top">12.5</td>
<td align="center" valign="top">Q1</td>
<td align="left" valign="top">Neurobiol Aging</td>
<td align="center" valign="top">318</td>
<td align="center" valign="top">6,721</td>
<td align="center" valign="top">3.7</td>
<td align="center" valign="top">Q2</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>Analysis of journals and co-cited-journals engaged in research on AI-related AD. <bold>(A)</bold> The number of publications of the top 10 journals. <bold>(B)</bold> Co-cited journal analysis displays the relationships between journals with a co-citation count of 50 or more. The size of each journal node corresponds to the number of articles published by that journal. The thickness of the curved lines connecting the nodes represents the level of collaboration between the journals. The color coding within the nodes indicates different clusters, each representing a group of journals with similar research affinities. <bold>(C)</bold> Double graphical overlay of journals. On the left were the citing journals, on the right were the cited journals, and the colored path represented the citation relationship.</p>
</caption>
<graphic xlink:href="fneur-15-1510729-g005.tif"/>
</fig>
<p>Journals that have garnered citations from multiple authors are designated as co-cited journals. As depicted in <xref ref-type="fig" rid="fig5">Figure 5B</xref>, we conducted a visual analysis focusing on these co-cited journals that received over 50 citations. Among them, the Alzheimer&#x2019;s &#x0026; Dementia emerged as the top contender, boasting an Impact Factor of 13 and a remarkable 820 citations. This was closely followed by the Neuroimage, with an Impact Factor of 4.7 and 740 citations, and the Journal of Alzheimer&#x2019;s Disease, holding an Impact Factor of 3.4 and 696 citations. These journals not only demonstrate their widespread influence within the field but also underscore their importance as key sources of information and research insights. <xref ref-type="table" rid="tab2">Table 2</xref> provides detailed information on journals and co-cited journals, which allows you to explore publication preferences among authors and provide useful references for future research.</p>
<p>Using the double-map overlay of journals shown in <xref ref-type="fig" rid="fig5">Figure 5C</xref>, we can see the left side displays the distribution of journals publishing the citing literature, reflecting the primary disciplines of the cited articles. The right side shows the journals where the cited literature appears, indicating the disciplines that frequently reference the material. Colored lines denote the citation connections between them.</p>
</sec>
<sec id="sec10">
<label>3.5</label>
<title>An analysis of the cited references and co-cited references</title>
<p>In order to build on existing knowledge and concepts, researchers need to know which works have gained the most attention and citations. <xref ref-type="table" rid="tab3">Table 3</xref> presents the top 10 most cited articles in the field of artificial intelligence and Alzheimer&#x2019;s disease research, with citation counts ranging from 103 to 321. The document with the highest global citations, &#x201C;Alzheimer&#x2019;s disease drug development pipeline: 2022&#x201D; authored by Jeffrey Cummings and colleagues, appeared in the journal Alzheimers Dement (N Y) in 2022 (<xref ref-type="bibr" rid="ref26">26</xref>). Following in second place is &#x201C;Deep Learning in Alzheimer&#x2019;s Disease: Diagnostic Classification and Prognostic Prediction Using Neuroimaging Data&#x201D; by Taeho Jo and team, which was published in Frontiers in Aging Neuroscience in 2019 (<xref ref-type="bibr" rid="ref27">27</xref>), garnering 281 citations. In third position, &#x201C;Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer&#x2019;s Disease&#x201D; by Sahil Khan and co-authors, earned 272 citations upon its publication in Current Neuropharmacology in 2020 (<xref ref-type="bibr" rid="ref1">1</xref>).</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>The top 10 most globally cited documents.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Rank</th>
<th align="left" valign="top">Literature</th>
<th align="center" valign="top">Total citations</th>
<th align="left" valign="top">Author</th>
<th align="center" valign="top">Year</th>
<th align="left" valign="top">Journal</th>
<th align="center" valign="top">IF (2023)</th>
<th align="center" valign="top">JCR (2023)</th>
<th align="left" valign="top">DOI</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">1</td>
<td align="left" valign="top">Alzheimer&#x2019;s disease drug development pipeline: 2022</td>
<td align="center" valign="top">321</td>
<td align="left" valign="top">Jeffrey Cummings</td>
<td align="center" valign="top">2022</td>
<td align="left" valign="top">Alzheimers Dement (N Y)</td>
<td align="center" valign="top">Q1</td>
<td align="center" valign="top">4.9</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.1002/trc2.12295" ext-link-type="uri">10.1002/trc2.12295</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">2</td>
<td align="left" valign="top">Deep Learning in Alzheimer&#x2019;s Disease: Diagnostic Classification and Prognostic Prediction Using Neuroimaging Data</td>
<td align="center" valign="top">281</td>
<td align="left" valign="top">Taeho Jo</td>
<td align="center" valign="top">2019</td>
<td align="left" valign="top">Front Aging Neurosci</td>
<td align="center" valign="top">Q2</td>
<td align="center" valign="top">4.1</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.3389/fnagi.2019.00220" ext-link-type="uri">10.3389/fnagi.2019.00220</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">3</td>
<td align="left" valign="top">Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer&#x2019;s Disease</td>
<td align="center" valign="top">272</td>
<td align="left" valign="top">Sahil Khan</td>
<td align="center" valign="top">2020</td>
<td align="left" valign="top">Curr Neuropharmacol</td>
<td align="center" valign="top">Q1</td>
<td align="center" valign="top">4.8</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.2174/1570159X18666200528142429" ext-link-type="uri">10.2174/1570159X18666200528142429</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">4</td>
<td align="left" valign="top">COVID-19 Artificial Intelligence Diagnosis Using Only Cough Recordings</td>
<td align="center" valign="top">252</td>
<td align="left" valign="top">Jordi Laguarta</td>
<td align="center" valign="top">2020</td>
<td align="left" valign="top">IEEE Open J Eng Med Biol</td>
<td align="center" valign="top">Q3</td>
<td align="center" valign="top">2.7</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.1109/OJEMB.2020.3026928" ext-link-type="uri">10.1109/OJEMB.2020.3026928</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">5</td>
<td align="left" valign="top">Global Evolution of Research in Artificial Intelligence in Health and Medicine: A Bibliometric Study</td>
<td align="center" valign="top">190</td>
<td align="left" valign="top">Bach Xuan Tran</td>
<td align="center" valign="top">2019</td>
<td align="left" valign="top">J Clin Med</td>
<td align="center" valign="top">Q1</td>
<td align="center" valign="top">3.0</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.3390/jcm8030360" ext-link-type="uri">10.3390/jcm8030360</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">6</td>
<td align="left" valign="top">Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer&#x2019;s disease: a machine learning approach</td>
<td align="center" valign="top">156</td>
<td align="left" valign="top">Christian Salvatore</td>
<td align="center" valign="top">2015</td>
<td align="left" valign="top">Front Neurosci</td>
<td align="center" valign="top">Q2</td>
<td align="center" valign="top">3.2</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.3389/fnins.2015.00307" ext-link-type="uri">10.3389/fnins.2015.00307</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">7</td>
<td align="left" valign="top">Diagnosis of Alzheimer&#x2019;s Disease via Multi-Modality 3D Convolutional Neural Network</td>
<td align="center" valign="top">130</td>
<td align="left" valign="top">Yechong Huang</td>
<td align="center" valign="top">2019</td>
<td align="left" valign="top">Front Neurosci</td>
<td align="center" valign="top">Q2</td>
<td align="center" valign="top">3.2</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.3389/fnins.2019.00509" ext-link-type="uri">10.3389/fnins.2019.00509</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">8</td>
<td align="left" valign="top">A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer&#x2019;s disease</td>
<td align="center" valign="top">124</td>
<td align="left" valign="top">Shaker El-Sappagh</td>
<td align="center" valign="top">2021</td>
<td align="left" valign="top">Scientific Reports</td>
<td align="center" valign="top">Q1</td>
<td align="center" valign="top">3.8</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.1038/s41598-021-82098-3" ext-link-type="uri">10.1038/s41598-021-82098-3</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">9</td>
<td align="left" valign="top">Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer&#x2019;s disease</td>
<td align="center" valign="top">115</td>
<td align="left" valign="top">Xiaoqi Wang</td>
<td align="center" valign="top">2020</td>
<td align="left" valign="top">Mol Neurodegener</td>
<td align="center" valign="top">Q1</td>
<td align="center" valign="top">14.9</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.1186/s13024-020-00395-3" ext-link-type="uri">10.1186/s13024-020-00395-3</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">10</td>
<td align="left" valign="top">Machine Learning-based Virtual Screening and Its Applications to Alzheimer&#x2019;s Drug Discovery: A Review</td>
<td align="center" valign="top">103</td>
<td align="left" valign="top">Kristy A Carpenter</td>
<td align="center" valign="top">2018</td>
<td align="left" valign="top">Curr Pharm Des</td>
<td align="center" valign="top">Q2</td>
<td align="center" valign="top">2.6</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.2174/1381612824666180607124038" ext-link-type="uri">10.2174/1381612824666180607124038</ext-link>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>A co-citation network is a graphical depiction of how frequently documents are cited together, indicating a conceptual link between them. Conceptual clusters form within this network when certain documents are consistently co-cited, signifying a shared research theme or focus. These clusters help identify central topics and influential works within an academic field. The top 10 co-cited references in the artificial intelligence and Alzheimer&#x2019;s disease field are listed in <xref ref-type="table" rid="tab4">Table 4</xref>. The most co-cited article is &#x201C;The diagnosis of dementia due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease (<xref ref-type="bibr" rid="ref28">28</xref>)&#x201D; (55 citations), followed by &#x201C;The diagnosis of mild cognitive impairment due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease (<xref ref-type="bibr" rid="ref29">29</xref>)&#x201D; (42 citations). The third most co-cited article is &#x201C;Mini-mental state. A practical method for grading the cognitive state of patients for the clinician&#x201D; and &#x201C;NIA-AA Research Framework: Toward a biological definition of Alzheimer&#x2019;s disease (<xref ref-type="bibr" rid="ref30">30</xref>)&#x201D; (38 citations). In order to construct a map of co-citations, references with a co-citation count of at least 15 were selected, a total of 52 references were selected for analysis of co-citations (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). There were different colors for different clusters of references. The first cluster (in red) included 21 references, while the second cluster (in green) included 18 references. Cluster 3 (in blue) included 7 references and Cluster 4 (in yellow) included 6 references. Citation surge denotes a rapid escalation in the frequency of citations within a brief timeframe, indicating the focal points of research interest for a specific duration and tracking the evolution of these focal points across different time periods. This phenomenon is also utilized to assess the dynamics and trajectory of emerging research trends. The top 25 references with the strongest citation burst are shown in <xref ref-type="fig" rid="fig6">Figure 6B</xref>. Among these, the publication titled &#x201C;NIA-AA Research Framework: Toward a biological definition of Alzheimer&#x2019;s disease (<xref ref-type="bibr" rid="ref30">30</xref>)&#x201D; authored by Clifford R Jack Jr. and colleagues in 2018 in the journal Alzheimers Dement, exhibited the most pronounced citation burst (strength&#x202F;=&#x202F;7.61), with the surge occurring between 2020 and 2024. This review proposes a biomarker-based definition of Alzheimer&#x2019;s disease, viewing it as a continuous pathological process and providing researchers with a common language to explore the intreractions between pathological changes and cognitive symptoms. In addition, we utilized CiteSpace to visualize the co-citation network of references, spanning the years 2010 to 2024 with yearly intervals, highlighting the key reference nodes. As shown in <xref ref-type="fig" rid="fig6">Figure 6C</xref>, each dot represents a reference, and they were grouped into different clusters based on their intersecting research areas, &#x201C;disease diagnosis&#x201D; (#0) is the largest cluster, followed by &#x201C;AI&#x201D; (#1), &#x201C;smart living&#x201D; (#2) and &#x201C;xai&#x201D; (#3). Subsequently, the timeline of key clusters was charted using CiteSpace, as displayed in <xref ref-type="fig" rid="fig6">Figure 6D</xref>, a temporal analysis shows that the hotspots of research have shifted from the original #9 early prediction, #8 random forests, #6 microstructure and #2 smart living to #1 ai, #3 xai, #4 machine learning, and #0 disease diagnosis.</p>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption>
<p>The top 10 most globally cited references.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Rank</th>
<th align="left" valign="top">Cited references</th>
<th align="center" valign="top">Co-cited counts</th>
<th align="left" valign="top">Author</th>
<th align="center" valign="top">Year</th>
<th align="left" valign="top">Journal</th>
<th align="center" valign="top">IF (2023)</th>
<th align="center" valign="top">JCR (2023)</th>
<th align="left" valign="top">DOI</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">1</td>
<td align="left" valign="top">The diagnosis of dementia due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease</td>
<td align="center" valign="top">55</td>
<td align="left" valign="top">Guy M McKhann</td>
<td align="center" valign="top">2011</td>
<td align="left" valign="top">Alzheimers Dement</td>
<td align="center" valign="top">Q1</td>
<td align="center" valign="top">13.1</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.1016/J.JALZ.2011.03.005" ext-link-type="uri">10.1016/J.JALZ.2011.03.005</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">2</td>
<td align="left" valign="top">The diagnosis of mild cognitive impairment due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease</td>
<td align="center" valign="top">42</td>
<td align="left" valign="top">Marilyn S Albert</td>
<td align="center" valign="top">2011</td>
<td align="left" valign="top">Alzheimers Dement</td>
<td align="center" valign="top">Q1</td>
<td align="center" valign="top">13.1</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.1016/J.JALZ.2011.03.008" ext-link-type="uri">10.1016/J.JALZ.2011.03.008</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">3</td>
<td align="left" valign="top">&#x201C;Mini-mental state&#x201D;. A practical method for grading the cognitive state of patients for the clinician</td>
<td align="center" valign="top">38</td>
<td align="left" valign="top">M&#x202F;F Folstein</td>
<td align="center" valign="top">1975</td>
<td align="left" valign="top">J Psychiatr Res</td>
<td align="center" valign="top">Q1</td>
<td align="center" valign="top">3.7</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.1016/0022-3956(75)90026-6" ext-link-type="uri">10.1016/0022-3956(75)90026-6</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">4</td>
<td align="left" valign="top">NIA-AA Research Framework: Toward a biological definition of Alzheimer&#x2019;s disease</td>
<td align="center" valign="top">38</td>
<td align="left" valign="top">Clifford R Jack Jr</td>
<td align="center" valign="top">2018</td>
<td align="left" valign="top">Alzheimers Dement</td>
<td align="center" valign="top">Q1</td>
<td align="center" valign="top">13.1</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.1016/J.JALZ.2018.02.018" ext-link-type="uri">10.1016/J.JALZ.2018.02.018</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">5</td>
<td align="left" valign="top">2018 Alzheimer&#x2019;s disease facts and figures</td>
<td align="center" valign="top">36</td>
<td align="left" valign="top">Alzheimer&#x2019;s Association</td>
<td align="center" valign="top">2018</td>
<td align="left" valign="top">Alzheimers Dement</td>
<td align="center" valign="top">Q1</td>
<td align="center" valign="top">13.1</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.1016/J.JALZ.2018.02.001" ext-link-type="uri">10.1016/J.JALZ.2018.02.001</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">6</td>
<td align="left" valign="top">Automated classification of Alzheimer&#x2019;s disease and mild cognitive impairment using a single MRI and deep neural networks</td>
<td align="center" valign="top">34</td>
<td align="left" valign="top">Silvia Basaia</td>
<td align="center" valign="top">2018</td>
<td align="left" valign="top">Neuroimage Clin</td>
<td align="center" valign="top">Q2</td>
<td align="center" valign="top">3.4</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.1016/J.NICL.2018.101645" ext-link-type="uri">10.1016/J.NICL.2018.101645</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">7</td>
<td align="left" valign="top">A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using 18F-FDG PET of the Brain</td>
<td align="center" valign="top">34</td>
<td align="left" valign="top">Yiming Ding</td>
<td align="center" valign="top">2019</td>
<td align="left" valign="top">Radiology</td>
<td align="center" valign="top">Q1</td>
<td align="center" valign="top">12.1</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.1148/RADIOL.2018180958" ext-link-type="uri">10.1148/RADIOL.2018180958</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">8</td>
<td align="left" valign="top">Deep Residual Learning for Image Recognition</td>
<td align="center" valign="top">33</td>
<td align="left" valign="top">Kaiming He</td>
<td align="center" valign="top">2016</td>
<td align="left" valign="top">IEEE Conference on Computer Vision and Pattern Recognition (CVPR)</td>
<td/>
<td/>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.1109/CVPR.2016.90" ext-link-type="uri">10.1109/CVPR.2016.90</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">9</td>
<td align="left" valign="top">The Alzheimer&#x2019;s Disease Neuroimaging Initiative (ADNI): MRI methods</td>
<td align="center" valign="top">27</td>
<td align="left" valign="top">Clifford R Jack Jr</td>
<td align="center" valign="top">2008</td>
<td align="left" valign="top">J Magn Reson Imaging</td>
<td align="center" valign="top">Q1</td>
<td align="center" valign="top">3.3</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.1002/JMRI.21049" ext-link-type="uri">10.1002/JMRI.21049</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">10</td>
<td align="left" valign="top">Toward defining the preclinical stages of Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease</td>
<td align="center" valign="top">27</td>
<td align="left" valign="top">Reisa A Sperling</td>
<td align="center" valign="top">2011</td>
<td align="left" valign="top">Alzheimers Dement</td>
<td align="center" valign="top">Q1</td>
<td align="center" valign="top">13.1</td>
<td align="left" valign="top">
<ext-link xlink:href="https://doi.org/10.1016/J.JALZ.2011.03.003" ext-link-type="uri">10.1016/J.JALZ.2011.03.003</ext-link>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>Visualization analysis of cited and co-cited references. <bold>(A)</bold> Cluster analysis of co-cited references. Different colors represent different clusters of co-cited references. <bold>(B)</bold> Representative burst citations in the top 25 references with the most powerful citation burst. <bold>(C)</bold> Co-cited references were grouped into clusters with dots denoting references and different colors denoting different clusters. <bold>(D)</bold> Timeline distribution of the top10 clusters.</p>
</caption>
<graphic xlink:href="fneur-15-1510729-g006.tif"/>
</fig>
</sec>
<sec id="sec11">
<label>3.6</label>
<title>An analysis of the authors and co-cited authors</title>
<p>A total of 2,900 authors published related articles on artificial intelligence and Alzheimer&#x2019;s disease based on the visualization chart of 530 screened publications. <xref ref-type="fig" rid="fig7">Figure 7A</xref> displays the top 10 authors ranked by publications. Among the authors, Castiglioni I and Liu Y are the leading contributors with the highest number of articles published, each having published 6 articles. Among the most local citation authors (<xref ref-type="fig" rid="fig7">Figure 7B</xref>), CASTIGLIONI I and SALVATORE C rank first, with a total of 28 local citations, respectively. Followed by JO T (25 local citations), NHO K (25 local citations) and SAYKIN AJ (25 local citations). We analyzed 24,305 co-cited authors, and those cited over 20 times were visually analyzed, as shown in <xref ref-type="fig" rid="fig7">Figure 7C</xref>, there were 87 authors who were cited more than 20 times in the analysis. Among them, 7 authors whose articles were cited more than 50 times, JACK CR stands out with the highest number of co-citations, followed closely by PETERSEN RC and SUK HI, which indicates their research is highly regarded and influential.</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption>
<p>Analysis of active authors engaged in AI-related AD research. <bold>(A)</bold> Top 10 authors in terms of publications. <bold>(B)</bold> Top 10 cited authors in terms of publications. <bold>(C)</bold> The co-citation network map of authors obtained by the VOSviewer. Node size represents the number of citations. The distance between two nodes indicates the relatedness of authors based on the co-citation link. The smaller the distance, the stronger the relatedness, as indicated by similar colored clusters.</p>
</caption>
<graphic xlink:href="fneur-15-1510729-g007.tif"/>
</fig>
</sec>
<sec id="sec12">
<label>3.7</label>
<title>An analysis of the keywords</title>
<p>Keywords, as standardized and specialized vocabulary, provide a comprehensive reflection of the research subject matter. Analyzing frequently occurring keywords visually can facilitate a clearer understanding of the focal points and trends within the area of study. As a result of our analysis, we identified 2,544 keywords related to artificial intelligence and Alzheimer&#x2019;s disease. <xref ref-type="table" rid="tab5">Table 5</xref> presents the top 20 most frequently occurring keywords along with their cumulative link strength. In the visualization, only keywords appearing at least 5 times were included, resulting in a total of 162 keywords that met the criteria and were displayed using VOSviewer. A similar colored node indicates that two keywords are within the same cluster, and the size of a node indicates the occurrence frequency of a keyword, whereas the distance between two words indicates the strength of a relationship between two words (<xref ref-type="fig" rid="fig8">Figures 8A</xref>,<xref ref-type="fig" rid="fig8">B</xref>). The most frequently used keywords were &#x201C;Alzheimer&#x2019;s disease,&#x201D; &#x201C;artificial intelligence,&#x201D; &#x201C;dementia,&#x201D; &#x201C;machine learning,&#x201D; and &#x201C;mild cognitive impairment&#x201D; and so on (<xref ref-type="table" rid="tab5">Table 5</xref>; <xref ref-type="fig" rid="fig8">Figures 8A</xref>,<xref ref-type="fig" rid="fig8">B</xref>).</p>
<table-wrap position="float" id="tab5">
<label>Table 5</label>
<caption>
<p>The top 20 keywords in artificial intelligence and Alzheimer&#x2019;s disease research.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Rank</th>
<th align="left" valign="top">Keyword</th>
<th align="center" valign="top">Occurrences</th>
<th align="center" valign="top">Total link strength</th>
<th align="center" valign="top">Rank</th>
<th align="left" valign="top">Keyword</th>
<th align="center" valign="top">Occurrences</th>
<th align="center" valign="top">Total link strength</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">1</td>
<td align="left" valign="top">Alzheimer &#x2018;s disease</td>
<td align="center" valign="top">152</td>
<td align="center" valign="top">2,714</td>
<td align="center" valign="top">11</td>
<td align="left" valign="top">MRI</td>
<td align="center" valign="top">45</td>
<td align="center" valign="top">315</td>
</tr>
<tr>
<td align="left" valign="top">2</td>
<td align="left" valign="top">Artificial intelligence</td>
<td align="center" valign="top">100</td>
<td align="center" valign="top">1,253</td>
<td align="center" valign="top">12</td>
<td align="left" valign="top">Disease</td>
<td align="center" valign="top">45</td>
<td align="center" valign="top">271</td>
</tr>
<tr>
<td align="left" valign="top">3</td>
<td align="left" valign="top">Dementia</td>
<td align="center" valign="top">60</td>
<td align="center" valign="top">628</td>
<td align="center" valign="top">13</td>
<td align="left" valign="top">National institute</td>
<td align="center" valign="top">36</td>
<td align="center" valign="top">314</td>
</tr>
<tr>
<td align="left" valign="top">4</td>
<td align="left" valign="top">Machine learning</td>
<td align="center" valign="top">50</td>
<td align="center" valign="top">852</td>
<td align="center" valign="top">14</td>
<td align="left" valign="top">Magnetic resonance imaging</td>
<td align="center" valign="top">29</td>
<td align="center" valign="top">227</td>
</tr>
<tr>
<td align="left" valign="top">5</td>
<td align="left" valign="top">Mild cognitive impairment</td>
<td align="center" valign="top">44</td>
<td align="center" valign="top">800</td>
<td align="center" valign="top">15</td>
<td align="left" valign="top">Brain</td>
<td align="center" valign="top">29</td>
<td align="center" valign="top">204</td>
</tr>
<tr>
<td align="left" valign="top">6</td>
<td align="left" valign="top">Deep learning</td>
<td align="center" valign="top">41</td>
<td align="center" valign="top">422</td>
<td align="center" valign="top">16</td>
<td align="left" valign="top">Recommendations</td>
<td align="center" valign="top">25</td>
<td align="center" valign="top">229</td>
</tr>
<tr>
<td align="left" valign="top">7</td>
<td align="left" valign="top">Diagnosis</td>
<td align="center" valign="top">33</td>
<td align="center" valign="top">510</td>
<td align="center" valign="top">17</td>
<td align="left" valign="top">Neuroimaging</td>
<td align="center" valign="top">25</td>
<td align="center" valign="top">204</td>
</tr>
<tr>
<td align="left" valign="top">8</td>
<td align="left" valign="top">Classification</td>
<td align="center" valign="top">28</td>
<td align="center" valign="top">392</td>
<td align="center" valign="top">18</td>
<td align="left" valign="top">Pet</td>
<td align="center" valign="top">25</td>
<td align="center" valign="top">175</td>
</tr>
<tr>
<td align="left" valign="top">9</td>
<td align="left" valign="top">Prediction</td>
<td align="center" valign="top">26</td>
<td align="center" valign="top">543</td>
<td align="center" valign="top">19</td>
<td align="left" valign="top">Risk</td>
<td align="center" valign="top">25</td>
<td align="center" valign="top">167</td>
</tr>
<tr>
<td align="left" valign="top">10</td>
<td align="left" valign="top">Biomarkers</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">188</td>
<td align="center" valign="top">20</td>
<td align="left" valign="top">Cognitive impairment</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">163</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig position="float" id="fig8">
<label>Figure 8</label>
<caption>
<p>Co-occurrence analysis of keywords. <bold>(A)</bold> Network visualization map of keywords. A keyword is represented by an item, and the size of an item indicates how frequently it appears. Clusters are represented by different colors, and links represent how frequently it appears. <bold>(B)</bold> Overlap visualization map of keywords. The keyword analysis is broken down by average publication year (blue for earlier publications, yellow for later publications). <bold>(C)</bold> Visualization of cluster analysis of keywords.</p>
</caption>
<graphic xlink:href="fneur-15-1510729-g008.tif"/>
</fig>
<p>Keywords that were more closely related were grouped into the same cluster and assigned the same color, thereby roughly indicating the research emphasis in recent studies. As show in <xref ref-type="fig" rid="fig8">Figure 8A</xref>, based on the results of this study, selected keywords can be roughly divided into 6 clusters, the cluster analysis revealed six distinct groups of keywords, each color-coded to reflect research themes. The red cluster, comprising 49 keywords, was predominantly associated with &#x201C;Alzheimer's disease&#x201D;, &#x201C;artificial intelligence&#x201D; and &#x201C;machine learning brain&#x201D;. The green cluster, containing 43 keywords, featured key terms like &#x201C;deep learning&#x201D;, &#x201C;prediction&#x201D; and &#x201C;magnetic resonance imaging&#x201D;. The blue cluster, with 29 keywords, concentrated on areas such as &#x201C;dementia&#x201D;, &#x201C;biomarkers&#x201D;, &#x201C;risk&#x201D; and &#x201C;cognitive impairment&#x201D;. The yellow cluster encompassed 17 keywords, highlighting &#x201C;early detection&#x201D;, &#x201C;automated detection&#x201D; and &#x201C;artificial neural network&#x201D;. The purple cluster, with its 12 main keywords, focused on &#x201C;mild cognitive impairment&#x201D;, &#x201C;national institute&#x201D; and &#x201C;diagnostic guidelines&#x201D;. Lastly, the light blue cluster primarily included &#x201C;diagnosis&#x201D;, &#x201C;neuroimaging&#x201D; and &#x201C;PET&#x201D;. <xref ref-type="fig" rid="fig8">Figure 8B</xref> presents an overlay visualization of author keywords, with blue indicating earlier appearances and yellow signifying more recent terms. In the past, keywords like &#x201C;discovery&#x201D; &#x201C;image classification&#x201D;, &#x201C;association workgroups&#x201D; and &#x201C;computer-aided diagnosis&#x201D; dominated the discussion, while recent topics include &#x201C;early detection&#x201D;, &#x201C;networking&#x201D;, &#x201C;ChatGPT&#x201D; and &#x201C;AI&#x201D;. In&#x202F;addition, CiteSpace was utilized to perform a log-likelihood ratio clustering analysis on the collected keywords, resulting in the identification of 14 distinct clusters, as depicted in <xref ref-type="fig" rid="fig8">Figure 8C</xref>. The most prominent clusters are Cluster #0, associated with deep learning, Cluster #1, focusing on neurodegenerative disease, Cluster #2, centered on sleep movements, and Cluster #3, concerning risk factors.</p>
</sec>
</sec>
<sec sec-type="discussion" id="sec13">
<label>4</label>
<title>Discussion</title>
<p>Before 2010, Alzheimer&#x2019;s treatments primarily managed symptoms without curing the disease. Traditional drugs like acetylcholinesterase inhibitors (donepezil, galantamine, lismin) and the NMDA receptor antagonist memantine aimed to enhance cognitive function and daily living but did not halt disease progression or reverse pathology (<xref ref-type="bibr" rid="ref31">31</xref>). This study utilizes bibliometric analysis to systematically assess the research landscape surrounding the use of artificial intelligence (AI) in Alzheimer&#x2019;s disease, concentrating on literature published from 2010 to 2024. By examining publication trends, identifying key contributors, and exploring thematic developments, the research seeks to highlight the role of AI in early diagnosis, disease monitoring, and the formulation of treatment strategies. The results indicate a significant increase in publications over the past few years, demonstrating a growing interest and potential in utilizing AI technologies to tackle the challenges associated with Alzheimer&#x2019;s disease research (<xref ref-type="bibr" rid="ref32">32</xref>, <xref ref-type="bibr" rid="ref33">33</xref>). Analysis of publication trends reveals a significant increase in research on the applications of artificial intelligence (AI) in Alzheimer&#x2019;s disease over the past decade, particularly from 2019 to 2024. In this period, 530 publications were recorded, with 361 being original research articles. This indicates a growing interest in the intersection of AI and neurodegenerative disorders. This increase is attributed to advancements in AI technologies that have facilitated new diagnostic and therapeutic approaches in clinical practice. AI&#x2019;s ability to analyze complex datasets, improve predictive modeling, and enhance patient outcomes has clearly driven further research in this field (<xref ref-type="bibr" rid="ref32">32</xref>, <xref ref-type="bibr" rid="ref34">34</xref>).</p>
<p>Contributions from various countries highlight the collaborative efforts in AI research focused on Alzheimer&#x2019;s disease. Leading nations like the United States, China, and India show different research priorities and strengths, combining both established and emerging scientific capabilities. The United States leads with 152 publications, underscoring its dominance in biomedical research and innovation. In contrast, China&#x2019;s rapid growth is evident with 100 publications. This highlights its emerging role as a key player in scientific research, particularly in applying AI to healthcare. Moreover, the analysis shows that international collaborations are crucial. They facilitate knowledge sharing and resource allocation, leading to a more unified strategy for tackling Alzheimer&#x2019;s disease with AI (<xref ref-type="bibr" rid="ref35">35</xref>, <xref ref-type="bibr" rid="ref36">36</xref>).</p>
<p>An analysis of research output indicates that top institutions are leading the rapidly growing field of Alzheimer&#x2019;s disease research. For example, Harvard University has published 47 papers. This underscores the significant influence prestigious institutions have on shaping research priorities and outcomes. The robust collaborative network, especially from Harvard Medical School, illustrates how the reputation of institutions can significantly affect both the quality and quantity of research output. However, the relationship between competition and collaboration among these institutions requires further investigation, as it may influence the pace of scientific discoveries and the overall landscape of artificial intelligence research in Alzheimer&#x2019;s disease. Understanding these institutional dynamics is crucial for fostering an environment that encourages innovation and successfully translates research findings into clinical applications (<xref ref-type="bibr" rid="ref37">37</xref>, <xref ref-type="bibr" rid="ref38">38</xref>).</p>
<p>This investigation reveals that influential literature on AI and Alzheimer&#x2019;s disease is concentrated in specific journals, particularly the &#x201C;Journal of Alzheimer&#x2019;s Disease&#x201D; and &#x201C;Alzheimer&#x2019;s and Dementia.&#x201D; The high citation rates of these journals show that they are important platforms for sharing critical findings with the scientific community. Citation analysis also shows how these leading journals facilitate knowledge exchange and support the growth of new research areas. This has important implications for researchers. By choosing high-impact journals, they can increase their visibility and connect with a larger audience (<xref ref-type="bibr" rid="ref39">39</xref>, <xref ref-type="bibr" rid="ref40">40</xref>).</p>
<p>An analysis of keywords provides novel insights into the thematic emphases of contemporary research. The prevalence of keywords such as &#x201C;Alzheimer&#x2019;s disease,&#x201D; &#x201C;artificial intelligence,&#x201D; and &#x201C;machine learning&#x201D; underscores the prominence of these concepts within the scholarly discourse. Furthermore, the organization of keywords into distinct thematic clusters highlights the development of specific research areas, including predictive analytics, imaging techniques, and biomarker identification. This analysis serves as a strategic framework for future research endeavors, delineating prospective pathways for exploration that correspond with contemporary scientific interests and clinical imperatives. Moreover, monitoring the temporal evolution of keywords can yield significant insights into changing research priorities and the assimilation of innovative technologies in Alzheimer&#x2019;s disease research, with particular emphasis on the integration of deep learning and advanced data analytics (<xref ref-type="bibr" rid="ref41">41</xref>, <xref ref-type="bibr" rid="ref42">42</xref>).</p>
<p>This study has several limitations that should be carefully considered. First, our dependence on the Web of Science database for literature retrieval may have led to the omission of important contributions found in other reputable databases, such as PubMed and CNKI. Furthermore, focusing solely on English-language publications limits our analysis, potentially leaving out valuable insights from research published in other languages. Although we aimed to provide a thorough overview of the research landscape, the lack of standardized criteria for assessing the quality of the literature could introduce biases, especially in how we interpret the findings. To achieve a more comprehensive understanding of the field, future studies should include a wider variety of databases and languages, as well as implement strict quality assessment protocols.</p>
</sec>
<sec sec-type="conclusions" id="sec14">
<label>5</label>
<title>Conclusion</title>
<p>In conclusion, our systematic analysis of the literature regarding artificial intelligence in the context of Alzheimer&#x2019;s disease highlights the swift advancement and increasing interest in this interdisciplinary field. By identifying key contributors, influential journals, and emerging research themes, we offer valuable insights that can steer future research and inform clinical practices. As technology and healthcare continue to converge, it is essential for researchers to stay updated on these developments, encouraging collaboration and innovative strategies to improve diagnostic and therapeutic methods for Alzheimer&#x2019;s disease.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec15">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec sec-type="author-contributions" id="sec16">
<title>Author contributions</title>
<p>XA: Visualization, Writing &#x2013; original draft. JH: Software, Writing &#x2013; original draft. BB: Data curation, Investigation, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. GW: Methodology, Software, Writing &#x2013; review &#x0026; editing. JX: Project administration, Writing &#x2013; review &#x0026; editing. WY: Investigation, Writing &#x2013; review &#x0026; editing. ZR: Funding acquisition, Project administration, Supervision, Writing &#x2013; review &#x0026; editing, Writing &#x2013; original draft.</p>
</sec>
<sec sec-type="funding-information" id="sec17">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was supported by grants from the National Natural Science Foundation of China (82160311, 82160225, 82060232), the Science and Technology Fund Project of Guizhou Health and Health Commission (grant no. gzwkj2021-356), the Basic Science Technology Project of Guizhou Province (grant no. ZK [2021] 412), and the Special Project of Academic New Seedling Cultivation and Free Exploration Innovation-Post-project subsidy of the National Natural Science Foundation of China, &#x201C;Thousand Levels&#x201D; of Guizhou Province High level Innovative Talents (grant no. gzwjrs 2023-012).</p>
</sec>
<ack>
<p>The authors particularly thank the participants and their contribution to this study.</p>
</ack>
<sec sec-type="COI-statement" id="sec18">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec25">
<title>Generative AI statement</title>
<p>The authors declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="sec19">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<fn id="fn0001">
<p><sup>1</sup><ext-link xlink:href="https://bibliometric.com/" ext-link-type="uri">https://bibliometric.com/</ext-link>
</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname> <given-names>S</given-names></name> <name><surname>Barve</surname> <given-names>KH</given-names></name> <name><surname>Kumar</surname> <given-names>MS</given-names></name></person-group>. <article-title>Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer's disease</article-title>. <source>Curr Neuropharmacol</source>. (<year>2020</year>) <volume>18</volume>:<fpage>1106</fpage>&#x2013;<lpage>25</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1570159X18666200528142429</pub-id>, PMID: <pub-id pub-id-type="pmid">32484110</pub-id></citation></ref>
<ref id="ref2"><label>2.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dubois</surname> <given-names>B</given-names></name> <name><surname>von Arnim</surname> <given-names>CAF</given-names></name> <name><surname>Burnie</surname> <given-names>N</given-names></name> <name><surname>Bozeat</surname> <given-names>S</given-names></name> <name><surname>Cummings</surname> <given-names>J</given-names></name></person-group>. <article-title>Biomarkers in Alzheimer's disease: role in early and differential diagnosis and recognition of atypical variants</article-title>. <source>Alzheimers Res Ther</source>. (<year>2023</year>) <volume>15</volume>:<fpage>175</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13195-023-01314-6</pub-id>, PMID: <pub-id pub-id-type="pmid">37833762</pub-id></citation></ref>
<ref id="ref3"><label>3.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maycotte</surname> <given-names>P</given-names></name> <name><surname>Mar&#x00ED;n-Hern&#x00E1;ndez</surname> <given-names>A</given-names></name> <name><surname>Goyri-Aguirre</surname> <given-names>M</given-names></name> <name><surname>Anaya-Ruiz</surname> <given-names>M</given-names></name> <name><surname>Reyes-Leyva</surname> <given-names>J</given-names></name> <name><surname>Cort&#x00E9;s-Hern&#x00E1;ndez</surname> <given-names>P</given-names></name></person-group>. <article-title>Mitochondrial dynamics and cancer</article-title>. <source>Tumour Biol</source>. (<year>2017</year>) <volume>39</volume>:<fpage>1010428317698391</fpage>. doi: <pub-id pub-id-type="doi">10.1177/1010428317698391</pub-id></citation></ref>
<ref id="ref4"><label>4.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scheltens</surname> <given-names>P</given-names></name> <name><surname>De Strooper</surname> <given-names>B</given-names></name> <name><surname>Kivipelto</surname> <given-names>M</given-names></name> <name><surname>Holstege</surname> <given-names>H</given-names></name> <name><surname>Ch&#x00E9;telat</surname> <given-names>G</given-names></name> <name><surname>Teunissen</surname> <given-names>CE</given-names></name> <etal/></person-group>. <article-title>Alzheimer's disease</article-title>. <source>Lancet</source>. (<year>2021</year>) <volume>397</volume>:<fpage>1577</fpage>&#x2013;<lpage>90</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(20)32205-4</pub-id>, PMID: <pub-id pub-id-type="pmid">33667416</pub-id></citation></ref>
<ref id="ref5"><label>5.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hajjo</surname> <given-names>R</given-names></name> <name><surname>Sabbah</surname> <given-names>DA</given-names></name> <name><surname>Abusara</surname> <given-names>OH</given-names></name> <name><surname>Al Bawab</surname> <given-names>AQ</given-names></name></person-group>. <article-title>A review of the recent advances in Alzheimer's disease research and the utilization of network biology approaches for prioritizing diagnostics and therapeutics</article-title>. <source>Diagnostics (Basel)</source>. (<year>2022</year>) <volume>12</volume>:<fpage>2975</fpage>. doi: <pub-id pub-id-type="doi">10.3390/diagnostics12122975</pub-id></citation></ref>
<ref id="ref6"><label>6.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaiserman</surname> <given-names>A</given-names></name> <name><surname>Koliada</surname> <given-names>A</given-names></name> <name><surname>Lushchak</surname> <given-names>O</given-names></name></person-group>. <article-title>Neuroinflammation in pathogenesis of Alzheimer's disease: phytochemicals as potential therapeutics</article-title>. <source>Mech Ageing Dev</source>. (<year>2020</year>) <volume>189</volume>:<fpage>111259</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mad.2020.111259</pub-id>, PMID: <pub-id pub-id-type="pmid">32450086</pub-id></citation></ref>
<ref id="ref7"><label>7.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname> <given-names>GS</given-names></name></person-group>. <article-title>Amyloid-&#x03B2; and tau: the trigger and bullet in Alzheimer disease pathogenesis</article-title>. <source>JAMA Neurol</source>. (<year>2014</year>) <volume>71</volume>:<fpage>505</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamaneurol.2013.5847</pub-id></citation></ref>
<ref id="ref8"><label>8.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zy&#x015B;k</surname> <given-names>M</given-names></name> <name><surname>Beretta</surname> <given-names>C</given-names></name> <name><surname>Naia</surname> <given-names>L</given-names></name> <name><surname>Dakhel</surname> <given-names>A</given-names></name> <name><surname>P&#x00E5;v&#x00E9;nius</surname> <given-names>L</given-names></name> <name><surname>Brismar</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Amyloid-&#x03B2; accumulation in human astrocytes induces mitochondrial disruption and changed energy metabolism</article-title>. <source>J Neuroinflammation</source>. (<year>2023</year>) <volume>20</volume>:<fpage>43</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12974-023-02722-z</pub-id>, PMID: <pub-id pub-id-type="pmid">36803838</pub-id></citation></ref>
<ref id="ref9"><label>9.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muralidar</surname> <given-names>S</given-names></name> <name><surname>Ambi</surname> <given-names>SV</given-names></name> <name><surname>Sekaran</surname> <given-names>S</given-names></name> <name><surname>Thirumalai</surname> <given-names>D</given-names></name> <name><surname>Palaniappan</surname> <given-names>B</given-names></name></person-group>. <article-title>Role of tau protein in Alzheimer's disease: the prime pathological player</article-title>. <source>Int J Biol Macromol</source>. (<year>2020</year>) <volume>163</volume>:<fpage>1599</fpage>&#x2013;<lpage>617</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.07.327</pub-id>, PMID: <pub-id pub-id-type="pmid">32784025</pub-id></citation></ref>
<ref id="ref10"><label>10.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wiltfang</surname> <given-names>J</given-names></name> <name><surname>Esselmann</surname> <given-names>H</given-names></name> <name><surname>Barnikol</surname> <given-names>UB</given-names></name></person-group>. <article-title>The use of artificial intelligence in Alzheimer's disease-personalized diagnostics and therapy</article-title>. <source>Psychiatr Prax</source>. (<year>2021</year>) <volume>48</volume>:<fpage>S31</fpage>&#x2013;<lpage>s36</lpage>. doi: <pub-id pub-id-type="doi">10.1055/a-1369-3133</pub-id>, PMID: <pub-id pub-id-type="pmid">33652485</pub-id></citation></ref>
<ref id="ref11"><label>11.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abadir</surname> <given-names>P</given-names></name> <name><surname>Oh</surname> <given-names>E</given-names></name> <name><surname>Chellappa</surname> <given-names>R</given-names></name> <name><surname>Choudhry</surname> <given-names>N</given-names></name> <name><surname>Demiris</surname> <given-names>G</given-names></name> <name><surname>Ganesan</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Artificial intelligence and technology Collaboratories: innovating aging research and Alzheimer's care</article-title>. <source>Alzheimers Dement</source>. (<year>2024</year>) <volume>20</volume>:<fpage>3074</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1002/alz.13710</pub-id>, PMID: <pub-id pub-id-type="pmid">38324244</pub-id></citation></ref>
<ref id="ref12"><label>12.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname> <given-names>K</given-names></name> <name><surname>Salcidua</surname> <given-names>S</given-names></name> <name><surname>Orellana</surname> <given-names>P</given-names></name> <name><surname>Sauma-P&#x00E9;rez</surname> <given-names>T</given-names></name> <name><surname>Le&#x00F3;n</surname> <given-names>T</given-names></name> <name><surname>Steinmetz</surname> <given-names>LCL</given-names></name> <etal/></person-group>. <article-title>Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer's disease</article-title>. <source>Alzheimers Res Ther</source>. (<year>2023</year>) <volume>15</volume>:<fpage>176</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13195-023-01304-8</pub-id>, PMID: <pub-id pub-id-type="pmid">37838690</pub-id></citation></ref>
<ref id="ref13"><label>13.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hang Kwok</surname> <given-names>SW</given-names></name> <name><surname>Sipka</surname> <given-names>C</given-names></name> <name><surname>Matthews</surname> <given-names>A</given-names></name> <name><surname>Lara</surname> <given-names>CP</given-names></name> <name><surname>Wang</surname> <given-names>G</given-names></name> <name><surname>Choi</surname> <given-names>KS</given-names></name></person-group>. <article-title>Predicting dementia risk for elderly community dwellers in primary care services using subgroup-specific prediction models</article-title>. <source>Annu Int Conf IEEE Eng Med Biol Soc</source>. (<year>2023</year>) <volume>2023</volume>:<fpage>1</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1109/EMBC40787.2023.10340793</pub-id></citation></ref>
<ref id="ref14"><label>14.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>S</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Zheng</surname> <given-names>H</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Zhao</surname> <given-names>H</given-names></name> <name><surname>Sang</surname> <given-names>X</given-names></name> <etal/></person-group>. <article-title>Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis</article-title>. <source>Int J Surg</source>. (<year>2023</year>) <volume>109</volume>:<fpage>2774</fpage>&#x2013;<lpage>83</lpage>. doi: <pub-id pub-id-type="doi">10.1097/JS9.0000000000000492</pub-id>, PMID: <pub-id pub-id-type="pmid">37216225</pub-id></citation></ref>
<ref id="ref15"><label>15.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>Y</given-names></name> <name><surname>Mao</surname> <given-names>Y</given-names></name> <name><surname>Jiang</surname> <given-names>S</given-names></name> <name><surname>Luo</surname> <given-names>S</given-names></name> <name><surname>Chen</surname> <given-names>X</given-names></name> <name><surname>Xiao</surname> <given-names>W</given-names></name></person-group>. <article-title>A bibliometric analysis of systematic reviews and meta-analyses in ophthalmology</article-title>. <source>Front Med (Lausanne)</source>. (<year>2023</year>) <volume>10</volume>:<fpage>1135592</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmed.2023.1135592</pub-id>, PMID: <pub-id pub-id-type="pmid">36936241</pub-id></citation></ref>
<ref id="ref16"><label>16.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>M</given-names></name> <name><surname>Sampson</surname> <given-names>M</given-names></name> <name><surname>Barrowman</surname> <given-names>N</given-names></name> <name><surname>Doja</surname> <given-names>A</given-names></name></person-group>. <article-title>Bibliometric analysis of neurology articles published in general medicine journals</article-title>. <source>JAMA Netw Open</source>. (<year>2021</year>) <volume>4</volume>:<fpage>e215840</fpage>. doi: <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.5840</pub-id>, PMID: <pub-id pub-id-type="pmid">33856477</pub-id></citation></ref>
<ref id="ref17"><label>17.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>D</given-names></name> <name><surname>Yang</surname> <given-names>B</given-names></name> <name><surname>Guan</surname> <given-names>B</given-names></name> <name><surname>Song</surname> <given-names>L</given-names></name> <name><surname>Liu</surname> <given-names>Q</given-names></name> <name><surname>Fan</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>A bibliometric analysis of Pyroptosis from 2001 to 2021</article-title>. <source>Front Immunol</source>. (<year>2021</year>) <volume>12</volume>:<fpage>731933</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.731933</pub-id>, PMID: <pub-id pub-id-type="pmid">34484243</pub-id></citation></ref>
<ref id="ref18"><label>18.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>B</given-names></name> <name><surname>Guo</surname> <given-names>Y</given-names></name> <name><surname>Lu</surname> <given-names>Y</given-names></name> <name><surname>Ma</surname> <given-names>D</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name></person-group>. <article-title>Bibliometric and visualization analysis of the application of inorganic nanomaterials to autoimmune diseases</article-title>. <source>Biomater Sci</source>. (<year>2024</year>) <volume>12</volume>:<fpage>3981</fpage>&#x2013;<lpage>4005</lpage>. doi: <pub-id pub-id-type="doi">10.1039/D3BM02015K</pub-id></citation></ref>
<ref id="ref19"><label>19.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Zheng</surname> <given-names>H</given-names></name> <name><surname>Jiang</surname> <given-names>ST</given-names></name> <name><surname>Liu</surname> <given-names>YG</given-names></name> <name><surname>Zhang</surname> <given-names>T</given-names></name> <name><surname>Zhang</surname> <given-names>JW</given-names></name> <etal/></person-group>. <article-title>Worldwide research trends on tumor burden and immunotherapy: a bibliometric analysis</article-title>. <source>Int J Surg</source>. (<year>2024</year>) <volume>110</volume>:<fpage>1699</fpage>&#x2013;<lpage>710</lpage>. doi: <pub-id pub-id-type="doi">10.1097/JS9.0000000000001022</pub-id>, PMID: <pub-id pub-id-type="pmid">38181123</pub-id></citation></ref>
<ref id="ref20"><label>20.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arruda</surname> <given-names>H</given-names></name> <name><surname>Silva</surname> <given-names>ER</given-names></name> <name><surname>Lessa</surname> <given-names>M</given-names></name> <name><surname>Proen&#x00E7;a</surname> <given-names>D</given-names> <suffix>Jr</suffix></name> <name><surname>Bartholo</surname> <given-names>R</given-names></name></person-group>. <article-title>VOSviewer and Bibliometrix</article-title>. <source>J Med Libr Assoc</source>. (<year>2022</year>) <volume>110</volume>:<fpage>392</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.5195/jmla.2022.1434</pub-id>, PMID: <pub-id pub-id-type="pmid">36589296</pub-id></citation></ref>
<ref id="ref21"><label>21.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Eck</surname> <given-names>NJ</given-names></name> <name><surname>Waltman</surname> <given-names>L</given-names></name></person-group>. <article-title>Software survey: VOSviewer, a computer program for bibliometric mapping</article-title>. <source>Scientometrics</source>. (<year>2010</year>) <volume>84</volume>:<fpage>523</fpage>&#x2013;<lpage>38</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11192-009-0146-3</pub-id>, PMID: <pub-id pub-id-type="pmid">20585380</pub-id></citation></ref>
<ref id="ref22"><label>22.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>JQ</given-names></name> <name><surname>Shen</surname> <given-names>QH</given-names></name> <name><surname>Han</surname> <given-names>YY</given-names></name> <name><surname>Wu</surname> <given-names>Y</given-names></name> <name><surname>He</surname> <given-names>XF</given-names></name> <name><surname>Li</surname> <given-names>DW</given-names></name> <etal/></person-group>. <article-title>Analysis of research status and trends on marine benthic dinoflagellate toxins: a bibliometric study based on web of science database and VOSviewer</article-title>. <source>Environ Res</source>. (<year>2023</year>) <volume>238</volume>:<fpage>117179</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.envres.2023.117179</pub-id>, PMID: <pub-id pub-id-type="pmid">37748671</pub-id></citation></ref>
<ref id="ref23"><label>23.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Zhao</surname> <given-names>S</given-names></name> <name><surname>Tan</surname> <given-names>L</given-names></name> <name><surname>Tan</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Ye</surname> <given-names>Z</given-names></name> <etal/></person-group>. <article-title>Frontier and hot topics in electrochemiluminescence sensing technology based on CiteSpace bibliometric analysis</article-title>. <source>Biosens Bioelectron</source>. (<year>2022</year>) <volume>201</volume>:<fpage>113932</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bios.2021.113932</pub-id>, PMID: <pub-id pub-id-type="pmid">35065388</pub-id></citation></ref>
<ref id="ref24"><label>24.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>C</given-names></name></person-group>. <article-title>Searching for intellectual turning points: progressive knowledge domain visualization</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2004</year>) <volume>1</volume>:<fpage>5303</fpage>&#x2013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0307513100</pub-id></citation></ref>
<ref id="ref25"><label>25.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>F</given-names></name> <name><surname>Gao</surname> <given-names>J</given-names></name> <name><surname>Kang</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Niu</surname> <given-names>Q</given-names></name> <name><surname>Liu</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Knowledge mapping of exosomes in autoimmune diseases: a bibliometric analysis (2002-2021)</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>939433</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.939433</pub-id>, PMID: <pub-id pub-id-type="pmid">35935932</pub-id></citation></ref>
<ref id="ref26"><label>26.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname> <given-names>J</given-names></name> <name><surname>Lee</surname> <given-names>G</given-names></name> <name><surname>Nahed</surname> <given-names>P</given-names></name> <name><surname>Kambar</surname> <given-names>M</given-names></name> <name><surname>Zhong</surname> <given-names>K</given-names></name> <name><surname>Fonseca</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Alzheimer's disease drug development pipeline: 2022</article-title>. <source>Alzheimers Dement (N Y)</source>. (<year>2022</year>) <volume>8</volume>:<fpage>e12295</fpage>. doi: <pub-id pub-id-type="doi">10.1002/trc2.12295</pub-id>, PMID: <pub-id pub-id-type="pmid">35516416</pub-id></citation></ref>
<ref id="ref27"><label>27.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname> <given-names>T</given-names></name> <name><surname>Nho</surname> <given-names>K</given-names></name> <name><surname>Saykin</surname> <given-names>AJ</given-names></name></person-group>. <article-title>Deep learning in Alzheimer's disease: diagnostic classification and prognostic prediction using neuroimaging data</article-title>. <source>Front Aging Neurosci</source>. (<year>2019</year>) <volume>11</volume>:<fpage>220</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnagi.2019.00220</pub-id>, PMID: <pub-id pub-id-type="pmid">31481890</pub-id></citation></ref>
<ref id="ref28"><label>28.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>McKhann</surname> <given-names>GM</given-names></name> <name><surname>Knopman</surname> <given-names>DS</given-names></name> <name><surname>Chertkow</surname> <given-names>H</given-names></name> <name><surname>Hyman</surname> <given-names>BT</given-names></name> <name><surname>Jack</surname> <given-names>CR</given-names> <suffix>Jr</suffix></name> <name><surname>Kawas</surname> <given-names>CH</given-names></name> <etal/></person-group>. <article-title>The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease</article-title>. <source>Alzheimers Dement</source>. (<year>2011</year>) <volume>7</volume>:<fpage>263</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jalz.2011.03.005</pub-id>, PMID: <pub-id pub-id-type="pmid">21514250</pub-id></citation></ref>
<ref id="ref29"><label>29.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname> <given-names>MS</given-names></name> <name><surname>DeKosky</surname> <given-names>ST</given-names></name> <name><surname>Dickson</surname> <given-names>D</given-names></name> <name><surname>Dubois</surname> <given-names>B</given-names></name> <name><surname>Feldman</surname> <given-names>HH</given-names></name> <name><surname>Fox</surname> <given-names>NC</given-names></name> <etal/></person-group>. <article-title>The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease</article-title>. <source>Alzheimers Dement</source>. (<year>2011</year>) <volume>7</volume>:<fpage>270</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jalz.2011.03.008</pub-id></citation></ref>
<ref id="ref30"><label>30.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jack</surname> <given-names>CR</given-names> <suffix>Jr</suffix></name> <name><surname>Bennett</surname> <given-names>DA</given-names></name> <name><surname>Blennow</surname> <given-names>K</given-names></name> <name><surname>Carrillo</surname> <given-names>MC</given-names></name> <name><surname>Dunn</surname> <given-names>B</given-names></name> <name><surname>Haeberlein</surname> <given-names>SB</given-names></name> <etal/></person-group>. <article-title>NIA-AA research framework: toward a biological definition of Alzheimer's disease</article-title>. <source>Alzheimers Dement</source>. (<year>2018</year>) <volume>14</volume>:<fpage>535</fpage>&#x2013;<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jalz.2018.02.018</pub-id>, PMID: <pub-id pub-id-type="pmid">29653606</pub-id></citation></ref>
<ref id="ref31"><label>31.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname> <given-names>X</given-names></name> <name><surname>Cui</surname> <given-names>W</given-names></name> <name><surname>Xie</surname> <given-names>X</given-names></name> <name><surname>Ma</surname> <given-names>W</given-names></name> <name><surname>Zhan</surname> <given-names>Y</given-names></name> <name><surname>Lin</surname> <given-names>Y</given-names></name></person-group>. <article-title>Treatment of Alzheimer's disease with framework nucleic acids</article-title>. <source>Cell Prolif</source>. (<year>2020</year>) <volume>53</volume>:<fpage>e12787</fpage>. doi: <pub-id pub-id-type="doi">10.1111/cpr.12787</pub-id>, PMID: <pub-id pub-id-type="pmid">32162733</pub-id></citation></ref>
<ref id="ref32"><label>32.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname> <given-names>Y</given-names></name> <name><surname>Jang</surname> <given-names>H</given-names></name> <name><surname>Lee</surname> <given-names>H</given-names></name></person-group>. <article-title>Potential applications of artificial intelligence in clinical trials for Alzheimer's disease</article-title>. <source>Life (Basel)</source>. (<year>2022</year>) <volume>12</volume>:<fpage>275</fpage>. doi: <pub-id pub-id-type="doi">10.3390/life12020275</pub-id></citation></ref>
<ref id="ref33"><label>33.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frizzell</surname> <given-names>TO</given-names></name> <name><surname>Glashutter</surname> <given-names>M</given-names></name> <name><surname>Liu</surname> <given-names>CC</given-names></name> <name><surname>Zeng</surname> <given-names>A</given-names></name> <name><surname>Pan</surname> <given-names>D</given-names></name> <name><surname>Hajra</surname> <given-names>SG</given-names></name> <etal/></person-group>. <article-title>Artificial intelligence in brain MRI analysis of Alzheimer's disease over the past 12 years: a systematic review</article-title>. <source>Ageing Res Rev</source>. (<year>2022</year>) <volume>77</volume>:<fpage>101614</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.arr.2022.101614</pub-id>, PMID: <pub-id pub-id-type="pmid">35358720</pub-id></citation></ref>
<ref id="ref34"><label>34.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winchester</surname> <given-names>LM</given-names></name> <name><surname>Harshfield</surname> <given-names>EL</given-names></name> <name><surname>Shi</surname> <given-names>L</given-names></name> <name><surname>Badhwar</surname> <given-names>A</given-names></name> <name><surname>Khleifat</surname> <given-names>AA</given-names></name> <name><surname>Clarke</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia</article-title>. <source>Alzheimers Dement</source>. (<year>2023</year>) <volume>19</volume>:<fpage>5860</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1002/alz.13390</pub-id>, PMID: <pub-id pub-id-type="pmid">37654029</pub-id></citation></ref>
<ref id="ref35"><label>35.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Liang</surname> <given-names>Y</given-names></name> <name><surname>Cao</surname> <given-names>S</given-names></name> <name><surname>Cai</surname> <given-names>P</given-names></name> <name><surname>Fan</surname> <given-names>Y</given-names></name></person-group>. <article-title>Application of artificial intelligence in geriatric care: bibliometric analysis</article-title>. <source>J Med Internet Res</source>. (<year>2023</year>) <volume>25</volume>:<fpage>e46014</fpage>. doi: <pub-id pub-id-type="doi">10.2196/46014</pub-id>, PMID: <pub-id pub-id-type="pmid">37351923</pub-id></citation></ref>
<ref id="ref36"><label>36.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pavlik</surname> <given-names>VN</given-names></name> <name><surname>Burnham</surname> <given-names>SC</given-names></name> <name><surname>Kass</surname> <given-names>JS</given-names></name> <name><surname>Helmer</surname> <given-names>C</given-names></name> <name><surname>Palmqvist</surname> <given-names>S</given-names></name> <name><surname>Vassilaki</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Connecting cohorts to diminish Alzheimer's disease (CONCORD-AD): a report of an international research collaboration network</article-title>. <source>J Alzheimers Dis</source>. (<year>2022</year>) <volume>85</volume>:<fpage>31</fpage>&#x2013;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.3233/JAD-210525</pub-id>, PMID: <pub-id pub-id-type="pmid">34776434</pub-id></citation></ref>
<ref id="ref37"><label>37.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>CH</given-names></name> <name><surname>Lin</surname> <given-names>CH</given-names></name> <name><surname>Lane</surname> <given-names>HY</given-names></name></person-group>. <article-title>Machine learning and novel biomarkers for the diagnosis of Alzheimer's disease</article-title>. <source>Int J Mol Sci</source>. (<year>2021</year>) <volume>22</volume>:<fpage>2761</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms22052761</pub-id></citation></ref>
<ref id="ref38"><label>38.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>van der Niet</surname> <given-names>AG</given-names></name> <name><surname>Bleakley</surname> <given-names>A</given-names></name></person-group>. <article-title>Where medical education meets artificial intelligence: 'Does technology care?'</article-title>. <source>Med Educ</source>. (<year>2021</year>) <volume>55</volume>:<fpage>30</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1111/medu.14131</pub-id>, PMID: <pub-id pub-id-type="pmid">32078175</pub-id></citation></ref>
<ref id="ref39"><label>39.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nyholm</surname> <given-names>S</given-names></name></person-group>. <article-title>Artificial intelligence and human enhancement: can AI technologies make us more (artificially) intelligent?</article-title> <source>Camb Q Healthc Ethics</source>. (<year>2024</year>) <volume>33</volume>:<fpage>76</fpage>&#x2013;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S0963180123000464</pub-id>, PMID: <pub-id pub-id-type="pmid">37646146</pub-id></citation></ref>
<ref id="ref40"><label>40.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Demir-Kaymak</surname> <given-names>Z</given-names></name> <name><surname>Turan</surname> <given-names>Z</given-names></name> <name><surname>Unlu-Bidik</surname> <given-names>N</given-names></name> <name><surname>Unkazan</surname> <given-names>S</given-names></name></person-group>. <article-title>Effects of midwifery and nursing students' readiness about medical artificial intelligence on artificial intelligence anxiety</article-title>. <source>Nurse Educ Pract</source>. (<year>2024</year>) <volume>78</volume>:<fpage>103994</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.nepr.2024.103994</pub-id>, PMID: <pub-id pub-id-type="pmid">38810350</pub-id></citation></ref>
<ref id="ref41"><label>41.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname> <given-names>CY</given-names></name> <name><surname>Ran</surname> <given-names>AR</given-names></name> <name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>Chan</surname> <given-names>VTT</given-names></name> <name><surname>Sham</surname> <given-names>K</given-names></name> <name><surname>Hilal</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>A deep learning model for detection of Alzheimer's disease based on retinal photographs: a retrospective, multicentre case-control study</article-title>. <source>Lancet Digit Health</source>. (<year>2022</year>) <volume>4</volume>:<fpage>e806</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2589-7500(22)00169-8</pub-id>, PMID: <pub-id pub-id-type="pmid">36192349</pub-id></citation></ref>
<ref id="ref42"><label>42.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>X</given-names></name> <name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Ip</surname> <given-names>FCF</given-names></name> <name><surname>Jiang</surname> <given-names>Y</given-names></name> <name><surname>Cao</surname> <given-names>H</given-names></name> <name><surname>Lv</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Deep learning-based polygenic risk analysis for Alzheimer's disease prediction</article-title>. <source>Commun Med (Lond)</source>. (<year>2023</year>) <volume>3</volume>:<fpage>49</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s43856-023-00269-x</pub-id>, PMID: <pub-id pub-id-type="pmid">37024668</pub-id></citation></ref>
</ref-list>
</back>
</article>